Molecular mechanisms underlying RB protein function

Nature Reviews Molecular Cell Biology

Volumn 14, Issue 5, 2013, Pages 297-306

  Dick, Frederick A ^a   Rubin, Seth M ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; E1A PROTEIN; F BOX PROTEIN; ONCOPROTEIN; PROTEIN E7; RETINOBLASTOMA PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; SV40 PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CHROMOSOMAL INSTABILITY; CHROMOSOME STRUCTURE; CRYSTAL STRUCTURE; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; ENZYME INHIBITION; GENOMIC INSTABILITY; KNOCKOUT MOUSE; MAMMAL CELL; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; TRANSACTIVATION;

ANIMALS; APOPTOSIS; CELL CYCLE; GENOMIC INSTABILITY; HUMANS; RETINOBLASTOMA PROTEIN;

EID: 84876808719     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm3567     Document Type: Review

References (92)

1. Friend, S. H. et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643-646 (1986). (Pubitemid 16008560)
2. Classon, M. & Harlow, E. The retinoblastoma tumour suppressor in development and cancer. Nature Rev. Cancer 2, 910-917 (2002). (Pubitemid 37328892)
3. Sherr, C. J. & McCormick, F. The RB and p53 pathways in cancer. Cancer Cell 2, 103-112 (2002). (Pubitemid 41039110)
4. van den Heuvel, S. & Dyson, N. J. Conserved functions of the pRB and E2F families. Nature Rev. Mol. Cell Biol. 9, 713-724 (2008).
5. Burkhart, D. L. & Sage, J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nature Rev. Cancer 8, 671-682 (2008).
6. Manning, A. L. & Dyson, N. J. RB: mitotic implications of a tumour suppressor. Nature Rev. Cancer 12, 20-226 (2012).
7. MacPherson, D. & Dyer, M. A. Retinoblastoma: from the two-hit hypothesis to targeted chemotherapy. Cancer Res. 67, 7547-7550 (2007). (Pubitemid 47281344)
8. Knudsen, E. S. & Knudsen, K. E. Tailoring to RB: tumour suppressor status and therapeutic response. Nature Rev. Cancer 8, 714-724 (2008).
9. Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262 (1998). (Pubitemid 28371346)
10. Lee, J.-O., Russo, A. A. & Pavletich, N. P. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391, 859-865 (1998). (Pubitemid 28157656)
11. Hassler, M. et al. Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture. Mol. Cell 28, 371-385 (2007). (Pubitemid 350030561)
12. Rubin, S. M., Gall, A. L., Zheng, N. & Pavletich, N. P. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylationinduced E2F release. Cell 123, 1093-1106 (2005). (Pubitemid 41785423)
13. Burke, J. R., Deshong, A. J., Pelton, J. G. & Rubin, S. M. Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. J. Biol. Chem. 285, 16286-16293 (2010).
14. Burke, J. R., Hura, G. L. & Rubin, S. M. Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control. Genes Dev. 26, 1156-1166 (2012).
15. Lee, C., Chang, J. H., Lee, H. S. & Cho, Y. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. Genes Dev. 16, 3199-3212 (2002). (Pubitemid 36025973)
16. Xiao, B. et al. Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation. Proc. Natl Acad. Sci. USA 100, 2363-2368 (2003). (Pubitemid 36297504)
17. Kim, H.-Y., Ahn, B.-Y. & Cho, Y. Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen. EMBO J. 20, 295-304 (2001). (Pubitemid 32099125)
18. Lee, J. O., Russo, A. A. & Pavletich, N. P. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391, 859-865 (1998). (Pubitemid 28157656)
19. Brehm, A. & Kouzarides, T. Retinoblastoma protein meets chromatin. Trends Biochem. Sci. 24, 142-145 (1999). (Pubitemid 29222713)
20. Morris, E. J. & Dyson, N. J. Retinoblastoma protein partners. Adv. Cancer Res. 82, 1-54 (2001). (Pubitemid 32613381)
21. Singh, M., Krajewski, M., Mikolajka, A. & Holak, T. A. Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences. J. Biol. Chem. 280, 37868-37876 (2005). (Pubitemid 41642398)
22. Binne, U. K. et al. Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit. Nature Cell Biol. 9, 225-232 (2007). (Pubitemid 46420866)
23. Longworth, M. S., Herr, A., Ji, J. Y. & Dyson, N. J. RBF1 promotes chromatin condensation through a conserved interaction with the condensin II protein dCAP-D3. Genes Dev. 22, 1011-1024 (2008). (Pubitemid 351544240)
24. Fera, D. et al. Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteins. Chem. Biol. 19, 518-528 (2012).
25. Dick, F. A. & Dyson, N. pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities. Mol. Cell 12, 639-649 (2003). (Pubitemid 37229084)
26. Julian, L. M., Palander, O., Seifried, L. A., Foster, J. E. & Dick, F. A. Characterization of an E2F1-specific binding domain in pRB and its implications for apoptotic regulation. Oncogene 27, 1572-1579 (2008). (Pubitemid 351347885)
27. Adams, P. D. et al. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-CDK complexes. Mol. Cell. Biol. 19, 1068-1080 (1999). (Pubitemid 29046850)
28. Hirschi, A. et al. An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nature Struct. Mol. Biol. 17, 1051-1057 (2010).
29. Pan, W., Cox, S., Hoess, R. H. & Grafstrom, R. H. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein. Cancer Res. 61, 2885-2891 (2001). (Pubitemid 32691930)
30. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323-330 (1995).
31. Hiebert, S. W., Chellappan, S. P., Horowitz, J. M. & Nevins, J. R. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6, 177-185 (1992).
32. Qin, X. Q., Chittenden, T., Livingston, D. M. & Kaelin, W. G. Jr. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6, 953-964 (1992).
33. Rubin, S. M. Deciphering the retinoblastoma protein phosphorylation code. Trends Biochem. Sci. 38, 12-19 (2013).
34. Brown, V. D., Phillips, R. A. & Gallie, B. L. Cumulative effect of phosphorylation of pRB on regulation of E2F activity. Mol. Cell. Biol. 19, 3246-3256 (1999). (Pubitemid 29193786)
35. Knudsen, E. S. & Wang, J. Y. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol. Cell. Biol. 17, 5771-5783 (1997). (Pubitemid 27411084)
36. Kolupaeva, V. & Janssens, V. PP1 and PP2A phosphatases - cooperating partners in modulating retinoblastoma protein activation. FEBS J. 280, 627-643 (2012).
37. Munro, S., Carr, S. M. & La Thangue, N. B. Diversity within the pRb pathway: is there a code of conduct? Oncogene 31, 4343-4352 (2012).
38. Knudsen, E. S. & Wang, J. Y. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem. 271, 8313-8320 (1996). (Pubitemid 26108665)
39. Harbour, J., Luo, R., Dei Santi, A., Postigo, A. & Dean, D. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98, 859-869 (1999). (Pubitemid 29446902)
40. Isaac, C. E. et al. The retinoblastoma protein regulates pericentric heterochromatin. Mol. Cell. Biol. 26, 3659-3671 (2006).
41. Talluri, S. et al. A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence. Mol. Cell. Biol. 30, 948-960 (2010).
42. Chicas, A. et al. Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 17, 376-387 (2010).
43. Dannenberg, J.-H., van Rossum, A., Schuijff, L. & te Riele, H. Ablation of the retinoblastoma gene family deregulates G1 control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14, 3051-3064 (2000).
44. Sage, J. et al. Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization. Genes Dev. 14, 3037-3050 (2000).
45. Bourgo, R. J. et al. RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional control. Mol. Cell 43, 663-672 (2011).
46. Moberg, K., Starz, M. A. & Lees, J. A. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16, 1436-1449 (1996). (Pubitemid 26095614)
47. Hurford, R. K. Jr, Cobrinik, D., Lee, M. H. & Dyson, N. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11, 1447-1463 (1997). (Pubitemid 27259855)
48. Cam, H. et al. A common set of gene regulatory networks links metabolism and growth inhibition. Mol. Cell 16, 399-411 (2004). (Pubitemid 39504794)
49. Litovchick, L. et al. Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol. Cell 26, 539-551 (2007). (Pubitemid 46779093)
50. Korenjak, M. et al. Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes. Cell 119, 181-193 (2004). (Pubitemid 39360901)
51. Litovchick, L., Florens, L. A., Swanson, S. K., Washburn, M. P. & DeCaprio, J. A. DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly. Genes Dev. 25, 801-813 (2011)
52. Pilkinton, M., Sandoval, R. & Colamonici, O. R. Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cyclephase-dependent context distinct from the Drosophila dREAM complex. Oncogene 26, 7535-7543 (2007). (Pubitemid 350207709)
53. Sadasivam, S., Duan, S. & DeCaprio, J. A. The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression. Genes Dev. 26, 474-489 (2012).
54. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000). (Pubitemid 30046295)
55. Chen, D. et al. Division and apoptosis of E2f-defient retinal progenitors. Nature 462, 925-929 (2009).
56. Chong, J. L. et al. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature 462, 930-934 (2009).
57. Ji, P. et al. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partialpenetrance Rb mutant. Mol. Cell 16, 47-58 (2004). (Pubitemid 39330151)
58. Gao, D. et al. Cdh1 regulates cell cycle through modulating the claspin/Chk1 and the Rb/E2F1 pathways. Mol. Biol. Cell 20, 3305-3316 (2009).
59. +/- mice. Nature Genet. 42, 83-88 (2010).
60. Schvartzman, J. M., Duijf, P. H., Sotillo, R., Coker, C. & Benezra, R. Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 19, 701-714 (2011).
61. Kabeche, L. & Compton, D. A. Checkpointindependent stabilization of kinetochore-microtubule attachments by Mad2 in human cells. Curr. Biol. 22, 638-644 (2012).
62. Bester, A. C. et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145, 435-446 (2011).
63. Gonzalo, S. et al. Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nature Cell Biol. 7, 420-428 (2005). (Pubitemid 40533133)
64. Benetti, R. et al. Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination. J. Cell Biol. 178, 925-936 (2007). (Pubitemid 47443317)
65. Manning, A. L., Longworth, M. S. & Dyson, N. J. Loss of pRB causes centromere dysfunction and chromosomal instability. Genes Dev. 24, 1364-1376 (2010).
66. Coschi, C. H. et al. Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive. Genes Dev. 24, 1351-1363 (2010).
67. van Harn, T. et al. Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes Dev. 24, 1377-1388 (2010).
68. Zhang, J. et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature 481, 329-334 (2012).
69. Trimarchi, J. M. & Lees, J. A. Sibling rivalry in the E2F family. Nature Rev. Mol. Cell Biol. 3, 11-20 (2002). (Pubitemid 135709914)
70. Wu, L. et al. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 421, 942-947 (2003). (Pubitemid 36288025)
71. Ianari, A. et al. Proapoptotic function of the retinoblastoma tumor suppressor protein. Cancer Cell 15, 184-194 (2009).
72. Helin, K. et al. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70, 337-350 (1992).
73. Seifried, L. A. et al. pRB-E2F1 complexes are resistant to adenovirus E1A-mediated disruption. J. Virol. 82, 4511-4520 (2008). (Pubitemid 351563687)
74. Cecchini, M. J. & Dick, F. A. The biochemical basis of CDK phosphorylation-independent regulation of E2F1 by the retinoblastoma protein. Biochem. J. 434, 297-308 (2011).
75. Wells, J., Yan, P. S., Cechvala, M., Huang, T. & Farnham, P. J. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase. Oncogene 22, 1445-1460 (2003). (Pubitemid 36390594)
76. Avni, D. et al. Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage. Mol. Cell 12, 735-746 (2003). (Pubitemid 37222493)
77. Calbo, J. et al. G1 cyclin/cyclin-dependent kinasecoordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression. J. Biol. Chem. 277, 50263-50274 (2002). (Pubitemid 36042174)
78. Carnevale, J., Palander, O., Seifried, L. A. & Dick, F. A. DNA damage signals through differentially modified E2F1 molecules to induce apoptosis. Mol. Cell. Biol. 32, 900-912 (2012).
79. Bosco, E. E. et al. The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. J. Clin. Invest. 117, 218-228 (2007). (Pubitemid 46048468)
80. Hallstrom, T. C., Mori, S. & Nevins, J. R. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 13, 11-22 (2008). (Pubitemid 350309738)
81. Irwin, M. S. et al. Chemosensitivity linked to p73 function. Cancer Cell 3, 403-410 (2003). (Pubitemid 38340308)
82. Carr, S. M., Munro, S., Kessler, B., Oppermann, U. & La Thangue, N. B. Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein. EMBO J. 30, 317-327 (2011)
83. Chan, H. M., Krstic-Demonacos, M., Smith, L., Demonacos, C. & La Thangue, N. B. Acetylation contro of the retinoblastoma tumour-suppressor protein. Nature Genet. 3, 667-674 (2001). (Pubitemid 32624423)
84. Markham, D., Munro, S., Soloway, J., O'Connor, D. P. & La Thangue, N. B. DNA-damage-responsive acetylation of pRb regulates binding to E2F-1. EMBO Rep. 7, 192-198 (2006).
85. Munro, S., Khaire, N., Inche, A., Carr, S. & La Thangue, N. B. Lysine methylation regulates the pRb tumour suppressor protein. Oncogene 29, 2357-2367 (2010).
86. Saddic, L. A. et al. Methylation of the retinoblastoma tumor suppressor by SMYD2. J. Biol. Chem. 285, 37733-37740 (2010).
87. Henley, S. A. & Dick, F. A. The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle. Cell Div. 7, 10 (2012).
88. Cobrinik, D. Pocket proteins and cell cycle control. Oncogene 24, 2796-2809 (2005). (Pubitemid 40638091)
89. Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295-300 (1992).
90. Lee, M. H. et al. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10, 1621-1632 (1996).
91. Cobrinik, D. et al. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10, 1633-1644 (1996). (Pubitemid 26268868)
92. Lamber, E.P. et al. Structural insights into the mechanism of phosphoregulation of the retinoblastoma protein. PLoS ONE 8, e58463 (2013).